For reference: semaglutide · STEP 2. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to reason…
glp1-mechanism
Page 5 of 6 · 132 questions tagged glp1-mechanism.
I would like to know how much of this is established and how much is a reasonable story. I understand the observation; what I do not understand is the mechanism…
The case in front of me: cagrilintide · five days. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
Numbers first: a GLP-1 receptor agonist · PIONEER-1. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
The particulars: survodutide · twenty-eight days. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
What I am working with: 0.25 mg · a GLP-1 receptor agonist. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I…
What I am working with: oral semaglutide · PIONEER-1. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
The particulars: semaglutide · FLOW. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear that…
Conditions: 15 mg · tirzepatide. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is an…
The case in front of me: tirzepatide · ten days. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review…
Numbers first: a GLP-1 receptor agonist · TRIUMPH-1. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
Conditions: ecnoglutide · seven days. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because…
I keep a written log of every draw with date, volume and syringe type. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may…
Conditions: semaglutide · STEP 5. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because it…
Conditions: liraglutide · forty-two days. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to…
Stated plainly: 1 mg · mazdutide. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear that…
The receptor pharmacology I can follow; the in vivo translation is where I lose the thread. I would like the axes of comparison first and the recommendation second. I…
Setup, so nobody has to ask: 7.5 mg · mazdutide. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would…
Details up front: 5 mg · dulaglutide. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
What I have: a GLP-1 receptor agonist · five days. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
For reference: 1.7 mg · ecnoglutide. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that come…
Conditions: semaglutide · ESSENCE. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that come up…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. The empirical answer seems settled. The explanation does…
Conditions: semaglutide · seven days. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because…